Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 years or older
- People who were first prescribed the medication Ustekinumab between January 1 and December 31, 2024
- People who have given written consent to take part in the study
Who may not be able to join:
- People with a serious active infection, such as active tuberculosis or active viral hepatitis
- People who are pregnant or breastfeeding
- People with a history of significant mental health conditions that, in the opinion of the investigator, could interfere with following the study procedures or medication schedule
- People who have been diagnosed with ulcerative colitis (a type of inflammatory bowel disease)
- People who have had, or currently have, a cancerous condition affecting the digestive system
- People with severe, poorly controlled long-term conditions affecting the liver, kidneys, heart and blood vessels, blood vessel inflammation, or diabetes
- People who have had problems with alcohol or drug misuse in the year before the study started (as reported by the patient)
- People who are currently taking part in another interventional clinical trial (a study where a treatment or procedure is being tested)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +7 707 413 8263
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The proportion of patients with a reduced level of disease activity by 30% or more according to the Crohn's Disease Activity Index
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.